Endevica Bio
Latest round
- Series A
Last raised
- Jun 2016
Total raised
- $1.7M
Investors
- 1
About Endevica Bio
Based in Illinois, US, and founded by Kenneth Gruber in 2009, Endevica Bio operates as a biotechnology company engaged in the development of drugs to treat cachexia due to cancer. The company is working on the development of a peptide therapeutic for treating cachexia due to cancer and other chronic conditions such as renal failure and congestive heart failure. The company’s product primary molecule TCMCB07 is a melanocortin-3/4 (MC4R) antagonist peptide that helps in significant lean muscle mass gain during the administration of the drug. TCMCB07, as of January 2023, has completed its pre-clinical animal trials.
Who invested in Endevica Bio
1 investor across 1 round
See all investors in Endevica Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2016
Amount
$1.7M
Investors
Questions about Endevica Bio
Who invested in Endevica Bio?
Endevica Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endevica Bio raised?
Endevica Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Endevica Bio last raise money?
Endevica Bio's most recent round on record is a Series A, in Jun 2016.
What does Endevica Bio do?
Based in Illinois, US, and founded by Kenneth Gruber in 2009, Endevica Bio operates as a biotechnology company engaged in the development of drugs to treat cachexia due to cancer.
Where is Endevica Bio headquartered?
Endevica Bio is headquartered in Northbrook, US.
Which VCs invest in companies like Endevica Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Endevica Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Endevica Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.